Search
for
Sort by
Research 631–660 of 1000+
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Novel potential therapeutic targets of alopecia areata
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results